Literature DB >> 15692985

The intracellular 52-kd Ro/SSA autoantigen in keratinocytes is up-regulated by tumor necrosis factor alpha via tumor necrosis factor receptor I.

Velia Gerl1, Björn Hostmann, Christa Johnen, Aderajew Waka, Markus Gerl, Frank Schumann, Rolf Klein, Andreas Radbruch, Falk Hiepe.   

Abstract

OBJECTIVE: Previous studies have shown that the nuclear Ro/SSA autoantigens involved in photosensitive cutaneous lupus manifestations are regulated by ultraviolet B (UVB) irradiation. UVB exposure triggers the release of tumor necrosis factor alpha (TNFalpha) from keratinocytes in the epidermis and from mast cells in the dermis. The present study aimed to characterize the effect of TNFalpha on messenger RNA (mRNA) and protein expression of the intracellular 52-kd Ro/SSA autoantigen in primary human keratinocytes and to elucidate the TNFalpha receptor (TNFR) signaling pathways mediating this effect.
METHODS: Expression of 52-kd Ro/SSA mRNA in primary human keratinocytes was investigated by quantitative real-time polymerase chain reaction (LightCycler system) using GAPDH as the housekeeping gene. Expression of 52-kd Ro/SSA protein was studied by flow cytometry after staining intracellular protein with IgG purified from an anti-52-kd Ro/SSA-positive serum. TNFR function was assessed by culturing cells in the presence and absence of neutralizing antibodies directed against the TNFR subunits TNFRI and TNFRII.
RESULTS: TNFalpha-induced up-regulation of 52-kd Ro/SSA mRNA expression peaked at 4 hours, followed by up-regulation of intracellular 52-kd Ro/SSA protein expression at 24 hours, independently of apoptosis. Between different donors, a high variability of both constitutive expression levels and TNFalpha-induced changes in 52-kd Ro/SSA mRNA and protein expression was observed. The up-regulatory effect of TNFalpha on 52-kd Ro/SSA mRNA and protein expression was inhibited by anti-TNFRI antibodies but enhanced by anti-TNFRII antibodies.
CONCLUSION: The finding that TNFalpha up-regulates 52-kd Ro/SSA expression in keratinocytes via TNFRI suggests that it may play a role in the pathogenesis of anti-Ro/SSA-associated cutaneous lupus erythematosus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15692985     DOI: 10.1002/art.20851

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

Review 1.  New insights into the pathogenesis of systemic lupus erythematosus.

Authors:  Vasileios C Kyttaris; Christina G Katsiari; Yuang-Taung Juang; George C Tsokos
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

2.  Interferon-alpha induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies.

Authors:  Linn Strandberg; Aurelie Ambrosi; Alexander Espinosa; Lars Ottosson; Maija-Leena Eloranta; Wei Zhou; Ase Elfving; Edward Greenfield; Vijay K Kuchroo; Marie Wahren-Herlenius
Journal:  J Clin Immunol       Date:  2008-05       Impact factor: 8.317

Review 3.  Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus.

Authors:  Jasmine N Stannard; J Michelle Kahlenberg
Journal:  Curr Opin Rheumatol       Date:  2016-09       Impact factor: 5.006

Review 4.  Apoptosis and autoimmunity.

Authors:  Jeannine S Navratil; Chau-Ching Liu; Joseph M Ahearn
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 5.  Immunopathogenesis of skin injury in systemic lupus erythematosus.

Authors:  Grace A Hile; J Michelle Kahlenberg
Journal:  Curr Opin Rheumatol       Date:  2021-03-01       Impact factor: 5.006

6.  Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients.

Authors:  François Danion; Laetitia Sparsa; Laurent Arnaud; Ghada Alsaleh; François Lefebvre; Vincent Gies; Thierry Martin; Cédric Lukas; Jean Durckel; Marc Ardizzone; Rose-Marie Javier; Jean-François Kleinmann; Paul Moreau; Gilles Blaison; Joelle Goetz; Emmanuel Chatelus; Jacques-Eric Gottenberg; Jean Sibilia; Christelle Sordet
Journal:  RMD Open       Date:  2017-12-29

7.  TWEAK/Fn14 Activation Participates in Ro52-Mediated Photosensitization in Cutaneous Lupus Erythematosus.

Authors:  Yale Liu; Meifeng Xu; Xiaoyun Min; Kunyi Wu; Ting Zhang; Ke Li; Shengxiang Xiao; Yumin Xia
Journal:  Front Immunol       Date:  2017-05-31       Impact factor: 7.561

Review 8.  Current concepts of photosensitivity in cutaneous lupus erythematosus.

Authors:  Benjamin Klein; Manfred Kunz
Journal:  Front Med (Lausanne)       Date:  2022-08-25

Review 9.  Pathophysiology of cutaneous lupus erythematosus.

Authors:  Julie H Lin; Jan P Dutz; Richard D Sontheimer; Victoria P Werth
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 10.817

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.